Re: A Shorter Regimen for Rifampin-Resistant Tuberculosis
Publication:
New England Journal of Medicine
Summary:
In accordance with the increasing recognition of multidrug-resistant and extensively drug-resistant tuberculosis worldwide, we believe that routine prescription of this shorter regimen based on rifampin resistance alone will lead to undertreatment of many patients worldwide.
Citation:
Tornheim J, Udwadia Z, Gupta A. Re: A Shorter Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med. 2019 Spt 12; 381(11): e22. doi: 10.1056/NEJMc1905782.
Read More: